Results of Annual General Meeting 2014 - Acrobat pdf 129k 21 November 2014 Pro Medicus announced the results of the Annual General Meeting (AGM), on 21 November 2014. The results may be downloaded via the above link.
Annual General Meeting November 2014 - Acrobat pdf 3,100k 21 November 2014 On 21 November 2014, Pro Medicus held their Annual General Meeting (AGM). The Chairman's Address, Chairman's Report, and CEO Address to the AGM are available for download via the above link.
PME Signs $8M Deal with WellSpan Health - Acrobat pdf 117k 20 November 2014 Key Points: WellSpan to use Pro Medicus’ Visage 7 technology for primary diagnoses and clinical distribution of medical images Seven-year deal, with base value to PME of A$8 million (US$7 million) Transaction-based model with potential upside Second large US deal for PME in past seven months Leading e-health company Pro Medicus Limited [ASX: PME] today announced the signing of an A$8 million (US$7 million) seven-year contract with WellSpan Health (“WellSpan”) – a large regional health network in the north-eastern United States. This is the second large US contract Pro Medicus has signed in the past seven months. The contract will see WellSpan use Pro Medicus’ Visage 7 technology as a core component of its new enterprise imaging platform for the next seven years, and possibly longer. WellSpan is a highly regarded, regional not-for-profit health network operating principally in the US states of (south central) Pennsylvania and (northern) Maryland. Impressively, WellSpan operates the region’s only accredited Level 1 Trauma Center and Primary Stroke Center. It spans 93 patient care locations and a network of four hospitals. WellSpan York Hospital, WellSpan Gettysburg Hospital, WellSpan Ephrata Community Hospital and the WellSpan Surgery & Rehabilitation Hospital. WellSpan serves a patient population of more than 650,000 people, has more than 11,000 employees, and is consistently ranked a top 100 US integrated healthcare network. The contract, which is based on an operational (transactional) model, covers a seven-year term with an estimated value to Pro Medicus in excess of A$8 million (US$7 million) over the life of the contract, with potential for further upside. Under the agreement, Visage 7 technology will be used throughout the WellSpan network for primary
PME Signs Large US Health Network - Acrobat pdf 110k 22 April 2014 Key Points: Large US health network to use Pro Medicus’ Visage 7 enterprise imaging platform for primary diagnoses and distribution of medical images Six-year deal, with base value to PME of $A20M Transaction-based model with potential upside Leading e-health company Pro Medicus Limited [ASX: PME] today announced the signing of a contract with a large US health network which will use Pro Medicus’ Visage 7 technology as a core component of its new enterprise imaging platform. Under the agreement, Visage technology will be used for primary diagnosis by radiologists, as well as distribution of diagnostic images to the client’s extensive base of referring physicians via electronic medical records integration. The contract, which is based on an operational (transaction) model, covers a six-year term with a base contract value of $A20M to Pro Medicus with potential for further upside as the use of the technology is expanded throughout the health system. Dr Sam Hupert, Pro Medicus’ CEO, said the deal was the culmination of efforts by our global team spanning Australia, Europe and the USA. “We are extremely pleased that a health system as large and well regarded as this one has recognized the unique benefits of our technology and the value it delivers.”
During one of the busiest times at RSNA 2013, Tuesday at Noon (to be exact), Visage Imaging and NVIDIA conducted an exciting video shoot in the Visage booth. Synergy between Visage 7 and NVIDIA® Quadro® technology was highlighted, (literally) putting the spotlight on the speed, scale, and impressive clinical capability of the Visage 7 Enterprise Imaging Platform. For customers who have not had the opportunity to attend RSNA or to see Visage 7 in action, the video provides an excellent lens into the energy of RSNA, as well as the clinical and technical dexterity of Visage 7. In the video, the multi-dimensional thin-client capabilities of Visage 7 are on center stage, demonstrating use on a variety of client platforms (PC and Mac), on single and multiple displays, using a variety of multi-modality presentations, non-DICOM visualization, and also showcasing mobile access via Visage Ease. When cutting-edge hardware and software work in tandem, the results are simply magical. Impressively at the 1:22 mark, be sure to take note of the visualization of digital breast tomosynthesis, better known as DBT or 3D mammography. Demonstrated at RSNA as a work-in-progress, the video highlights the 3D MIP for DBT, displayed side by side with CC and MLO views. These massive DBT studies dwarf even the largest imaging studies of the past, encompassing 1.5 gigabyte (GB) images per view, per breast, totaling 6 GB for each study. Due to patented Visage technology, server-side processing, and the powerful capabilities of NVIDIA Quadro, Visage 7 can display the massive DBT dataset for diagnostic interpretation over the LAN or WAN in approximately 2-3 seconds, down to high speed bandwidth connections (~6 Mbps). Because Visage 7 uses adaptive, intelligent streaming, the workarounds of legacy
Visage Imaging @ RSNA 2013 For all who attended, thank you for making RSNA 2013 such a success for Visage Imaging. It was great spending time with customers, demonstrating our latest innovations, and hearing about your plans for enterprise imaging initiatives in 2014. Similar to last year, we’ve developed our “top five” observations coming out of the conference. If you had similar or different observations, we’d love to hear about your views on any of our social media platforms. If you didn’t attend RSNA, we hope you find the observations valuable: 1. Take the lead. There’s a great dichotomy that has developed in medical imaging—while there’s an undertone of uncertainty in the US due to a variety of environmental factors, leading imaging organizations are moving forward seizing the opportunity to differentiate and separate from competitors. Visage 7 Workstation As legacy PACS have aged, no organization has coveted upgrading or replacing ‘PACS with PACS’ for negligible gain; however, times have changed. Whereas conventional solutions offer competitive parity, leading organizations have recognized that Visage 7, independently or in combination with other best of breed solutions, offers dramatic step-change improvements that leapfrog the status quo. Of note, respected industry analyst Frost & Sullivan* explained in their “RSNA 2013 Review”, Visage 7 “emphasized high performance [and] distinguished from other universal viewers as being an end-to-end viewer that can overlay existing PACS viewers and be used across several imaging specialties for primary diagnosis as well as for secondary viewing by clinicians.” While some lessor competitors are strategically comatose, top organizations have decided to break from the pack and move ahead. Michael Gray was arguably the first to write about this strategy following RSNA 2013, and Joe
Results of Annual General Meeting 2013 - Acrobat pdf 28k 22 November 2013 Pro Medicus announced the results of the Annual General Meeting (AGM), on 22 November 2013. The results may be downloaded via the above link.
Annual General Meeting November 2013 - Acrobat pdf 2,400k 22 November 2013 On 22 November 2013, Pro Medicus held their Annual General Meeting (AGM). The Chairman's Address, Chairman's Report, and CEO Address to the AGM are available for download via the above link.
Visage Technology Goes Live at vRad - Acrobat pdf 28k 21 November 2013 Key Points: First Visage 7 implementation goes live as part of the vRad partnership announced in May 2013 Visage 7 is a key component of vRad’s RG2 (Radiology Group 2.0) solution Visage technology delivers industry leading performance Five-year contract period commences Opens opportunities for further Visage rollout with vRad’s RG2 deployments Leading e-health company Pro Medicus Limited [ASX: PME] today announced that its Visage 7 imaging technology has been successfully implemented as part of RG2SM, vRad’s next- generation radiology operational management solution. RG2 – or Radiology Group 2.0 – optimizes coverage of both onsite and cloud based radiology services using physician productivity tools such as a next-generation radiology reading platform with Visage’s enterprise diagnostic viewer, global worklists and advanced analytics for faster and better decision making. vRad (Virtual Radiologic), based in Minneapolis, Minnesota, USA, is the country’s largest radiology group and telemedicine platform. vRad works in partnership with local radiology groups and hospitals to optimize radiology’s pivotal role in patient care. vRad’s more than 450 radiologists serve over 2,000 radiology groups, hospitals and health systems, reading in excess of 7 million studies annually. “This is an important milestone for us,” said Dr Sam Hupert, Pro Medicus CEO. “Our technology has proven its capability with a partner operating in a high-volume, high-demand healthcare environment. Not only does it provide vRad radiologists with the most comprehensive set of clinical tools in a single product, but it is also exceptionally fast. Unlike others who have to move ever increasing datasets across the network, we are able to instantly stream the images to radiologists’ desktops regardless of the size of the examination they are reading. Faster delivery
PME Signs US $4M Deal with Large Veterans Affairs Network - Acrobat pdf 37k 21 October 2013 Key Points: Pro Medicus’ first US government contract Contract is with VISN23 – a large regional veteran affairs network servicing more than 400,000 veterans Pro Medicus’ Visage 7 will be the central component of new, leading-edge technology platform Five-year contract worth more than US $4 million Leading e-health company Pro Medicus [ASX: PME] today announced its wholly-owned subsidiary, Visage Imaging Inc. (“Visage”), has signed a five-year US $4million agreement with VISN23, a large regional veterans affairs network in the United States of America. The VISN23 network, one of 21 Veteran Integrated Service Networks within the Department of Veterans Affairs (VA), serves more than 400,000 enrolled Veterans residing in the states of Iowa, Minnesota, Nebraska, North Dakota, South Dakota and portions of Illinois, Kansas, Missouri, Wisconsin and Wyoming. Under the terms of the agreement, Pro Medicus’ Visage 7 technology will be used for both diagnostic interpretation and clinical (referrer) distribution in all the radiology facilities covered by the network. Dr Sam Hupert, CEO of Pro Medicus Ltd, said, “This is an extremely important sale for Pro Medicus. It is our first US government contract and we expect this may open up further opportunities for us within both the extensive US veterans affairs network and the broader government market. Secondly, it confirms our view that our technology is not limited to just one segment of the radiology market. It is ideally suited to the full spectrum of radiology businesses allowing us to address opportunities ranging from teleradiology/remote reading groups all the way through to large government enterprises.” It is estimated that the rollout of Visage technology will commence in early 2014